In DM patients, the frequencies of circulating CD4+ PD-1+ cells are remarkably enhanced and are an accurate dermatomyositis biomarker for diagnosis and bad prognosis (AUC = 0.79) [33]. The gene discussed is CD4; the disease is dermatomyositis.